Labcorp Named to FORTUNE Magazine's 2021 "World's Most Admired Companies" Making the Annual List for the Third Time
Labcorp is thrilled to have been named to Fast Company magazine’s list of 2021 Most Innovative Companies. Labcorp was cited for playing a leading role in the fight against #COVID-19 by advancing science-based testing, partnering with biopharmaceutical companies to accelerate treatment and vaccine trials, and providing critical support services so people can return to work and to life activities. “The recognition by Fast Company is a testament to our leadership in science and the commitment of our global employees to improve health and improve lives,” said Adam Schechter, chairman and CEO.
Covance, Labcorp's Drug Development Business, Acclaimed by Frost & Sullivan as 2020 Global CRO Company of the Year Award for Its Unmatched Breadth of Services to Support Clinical Trials
We are incredibly proud to share that Forbes named LabCorp, our parent company, as one of the 2020 World's Best Employers AND as one of the Best Employers for New Graduates. Thank you to each of our nearly 65,000 team members across the globe for all that you do to make this a great place to work! https://careers.covance.com
Improving health and improving lives isn’t just for patients around the world – we’re also focusing on our employees’ overall well-being and quality of life. We’re proud to share our parent company, LabCorp, was recognized with the platinum award: Best Employers: Excellence in Health & Well-Being by Business Group on Health.
Our Central Labs pivoted during #COVID19 to seamlessly deliver for sponsors. Find out how we’re using learnings to improve future studies.
Tempus and LabCorp Announce Collaboration to Accelerate Clinical Trial Patient Participation
The healthcare industry is always looking to the future... to discover a better treatment... to deliver a cure... to prevent disease?to improve the quality of life. And it?s our mission to help speed that process. Our sparC Magazine is a glimpse into the latest innovations that are bringing continuity to the trial process, closing information gaps and de-risking projects.
LabCorp has announced that Covance has completed the transaction to acquire GlobalCare Clinical Trials, a globally recognized industry leader in patient-centric decentralized clinical trials (DCTs).